User contributions
(newest | oldest) View (newer 20 | older 20) (20 | 50 | 100 | 250 | 500)
- 19:18, 26 June 2020 (diff | hist) . . (+19) . . Sandbox
- 19:16, 26 June 2020 (diff | hist) . . (+43) . . N Sandbox (Sandbox)
- 22:15, 26 December 2019 (diff | hist) . . (-1) . . m Valproate (→State of the art) (current)
- 22:13, 26 December 2019 (diff | hist) . . (-35) . . m Valproate (→State of the art)
- 22:12, 26 December 2019 (diff | hist) . . (+7) . . m Valproate (→State of the art)
- 22:10, 26 December 2019 (diff | hist) . . (+1) . . m Valproate (→Medical use and TDM)
- 22:09, 26 December 2019 (diff | hist) . . (+1) . . m Valproate (→Medical use and TDM)
- 22:08, 26 December 2019 (diff | hist) . . (-6) . . m Valproate (→Pharmacokinetics of VPA)
- 22:05, 26 December 2019 (diff | hist) . . (-25) . . m Valproate (→Pathophysiology of epilepsy)
- 22:04, 26 December 2019 (diff | hist) . . (+2) . . m Valproate (→Pathophysiology of epilepsy)
- 22:02, 26 December 2019 (diff | hist) . . (0) . . m Valproate (→Pathophysiology of epilepsy)
- 22:02, 26 December 2019 (diff | hist) . . (-50) . . m Valproate (→Mechanism of action)
- 22:00, 26 December 2019 (diff | hist) . . (+4) . . m Valproate (→Genetic Pathophysiology and Seizure types)
- 22:00, 26 December 2019 (diff | hist) . . (+6) . . m Valproate (→Genetic Pathophysiology and Seizure types)
- 21:59, 26 December 2019 (diff | hist) . . (+7) . . m Valproate (→Genetic and General Pathophysiology)
- 21:58, 26 December 2019 (diff | hist) . . (+11) . . m Valproate (→Genetic Pathophysiology)
- 21:53, 26 December 2019 (diff | hist) . . (+3) . . m Valproate (→Structure and interaction with albumin)
- 21:52, 26 December 2019 (diff | hist) . . (0) . . m Valproate (→General)
- 13:39, 26 December 2019 (diff | hist) . . (-4) . . Valproate (→General)
- 15:05, 19 December 2019 (diff | hist) . . (+264) . . Valproate (→Medical use and TDM)
(newest | oldest) View (newer 20 | older 20) (20 | 50 | 100 | 250 | 500)